Radiolabeled Monoclonal Antibody Therapy
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for Radiolabeled Monoclonal Antibody Therapy, covering 2009-03-03 to 2019-03-28. Get the full timeline:
Most recent: Clinical Trial Update: Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery [Phase 1, Phase 2]